| Members |
associationTargetComponent |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) |
pM1 |
| pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) |
pM1 |
| pM1 category |
pM1 |
| pM1: Distant metastasis (breast) |
pM1 |
| pM1: Distant metastasis, includes separate tumour nodule(s) in a different lobe (ipsilateral or contralateral) (lung) |
pM1 |
| pM1a (III): Tumour extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) |
pM1a |
| pM1a category |
pM1a |
| pM1a: Distant metastasis (oesophagus) |
pM1a |
| pM1a: Distant metastasis not applicable (midthoracic oesophagus) |
pM1a |
| pM1a: Distant metastasis to bone marrow (retinoblastoma) |
pM1a |
| pM1a: Distant metastasis to lung (bone) |
pM1a |
| pM1a: Distant metastasis to lung (primitive neuroectodermal tumour/Ewing's sarcoma) |
pM1a |
| pM1a: Distant metastasis to non-regional lymph node(s) (prostate) |
pM1a |
| pM1a: Metastasis in coeliac lymph nodes (lower thoracic oesophagus) |
pM1a |
| pM1a: Metastasis in cervical nodes (upper thoracic oesophagus) |
pM1a |
| pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) |
pM1a |
| pM1a: Non-regional nodal or pulmonary metastasis (testis) |
pM1a |
| pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) |
pM1b |
| pM1b category |
pM1b |
| pM1b: Distant metastasis (oesophagus) |
pM1b |
| pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis) |
pM1b |
| pM1b: Distant metastasis to bone(s) (prostate) |
pM1b |
| pM1b: Distant metastasis to site other than coeliac lymph nodes (lower thoracic oesophagus) |
pM1b |
| pM1b: Distant metastasis to site other than cervical nodes (upper thoracic oesophagus) |
pM1b |
| pM1b: Distant metastasis to site other than lung (bone) |
pM1b |
| pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumour/Ewing's sarcoma) |
pM1b |
| pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma) |
pM1b |
| pM1b: Metastasis to lung (melanoma of the skin) |
pM1b |
| pM1b: Nonregional lymph nodes and/or other distant metastasis (midthoracic oesophagus) |
pM1b |
| pM1c category |
pM1c |
| pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate) |
pM1c |
| pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) (melanoma of the skin) |
pM1c |
| pMX category |
cM0 |
| pMX: Distant metastasis cannot be assessed (breast) |
cM0 |
| pN category finding |
American Joint Committee on Cancer pathological N category allowable value |
| pN0 category |
pN0 |
| pN0(i+) category |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive IHC, no IHC cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumour cells, no cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i-) category |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative IHC (breast) |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast) |
pN0 |
| pN0(mol+) category |
pN0(mol+) |
| pN0(mol+): No regional lymph node metastasis histologically, positive molecular findings (breast) |
pN0(mol+) |
| pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumour cells (breast) |
pN0(mol+) |
| pN0(mol-) category |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative molecular findings (breast) |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumour cells (breast) |
pN0 |
| pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumour cells (breast) |
pN0 |
| pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
pN1 |
| pN1 (IVA): Pelvic or inguinal lymph node metastasis (pT4) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (IVA): Unilateral regional lymph node metastasis (pT4) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 (IVB): Pelvic or inguinal lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (IVB): Unilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 category |
pN1 |
| pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
pN1 |
| pN1: Metastasis in 1 to 3 regional lymph nodes (colon/rectum) |
pN1 |
| pN1: Metastasis in 1 to 6 regional (perigastric) lymph nodes (stomach) |
pN1 |
| pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension (upper aerodigestive tract) |
pN1 |
| pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN1 |
| pN1: Metastasis in a single regional lymph node (kidney) |
pN1 |
| pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumour (lung) |
pN1 |
| pN1: Metastasis in one regional lymph node (melanoma of the skin) |
pN1 |
| pN1: Metastasis in perirectal lymph node(s) (anal canal) |
pN1 |
| pN1: Metastasis in the ipsilateral bronchopulmonary and/or hilar lymph node(s) (thoracic mesothelioma) |
pN1 |
| pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension and less than or equal to 5 nodes positive, none more than 2 cm in greatest dimension (testis) |
pN1 |
| pN1: Pelvic or inguinal lymph node metastasis (vagina) |
pN1 |
| pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) |
pN1 |
| pN1: Unilateral regional lymph node metastasis (vulva) |
pN1 |
| pN1a category |
pN1a |
| pN1a: Clinically occult (microscopic) metastasis (melanoma of the skin) |
pN1a |
| pN1a: Metastasis in 1 to 3 axillary lymph nodes (at least one tumour deposit greater than 2.0 mm) (breast) |
pN1a |
| pN1a: Metastasis in 1 to 3 regional lymph nodes (oesophagus) |
pN1a |
| pN1a: Metastasis in single regional lymph node (exocrine pancreas) |
pN1a |
| pN1a: Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) (thyroid) |
pN1a |
| pN1b category |
pN1b |
| pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
pN1b |
| pN1b: Metastasis in 4 to 7 regional lymph nodes (oesophagus) |
pN1b |
| pN1b: Metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
pN1b |
| pN1b: Metastasis in multiple regional lymph node(s) (exocrine pancreas) |
pN1b |
| pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes (thyroid) |
pN1b |
| pN1c category |
pN1c |
| pN1c: Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
pN1c |
| pN1c: Metastasis in more than 7 regional lymph nodes (oesophagus) |
pN1c |
| pN1mi category |
pN1mi |
| pN1mi(i+): Micrometastasis detected only by immunohistochemistry (breast) |
pN1mi |
| pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast) |
pN1mi |
| pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) |
pN2 |
| pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) |
pN2 |
| pN2 category |
pN2 |
| pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) |
pN2 |
| pN2: Bilateral regional lymph node metastasis (vulva) |
pN2 |
| pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) |
pN2 |
| pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) |
pN2 |
| pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) |
pN2 |
| pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) |
pN2 |
| pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN2 |
FHIR